Scholar Data
Sign in

Automated Organization Profile

Department of Psychiatry, Boston VA Medical Center West Roxbury, Veterans Affairs Boston Healthcare System and Harvard Medical School

Current S-Index

1.0

Sum of Dataset Indices for all datasets

Average Dataset Index per Dataset

0.3

Average Dataset Index per dataset

Total Datasets

4

Total datasets in this organization

Average FAIR Score

78.8%

Average FAIR Score per dataset

Total Citations

0

Total citations to the organization's datasets

Total Mentions

0

Total mentions of the organization's datasets

S-Index Interpretation

S-Index Over Time

Cumulative Citations Over Time

Cumulative Mentions Over Time

Datasets

Data for article "Personal approach for cancer treatment: a meta-analysis of Phase II Clinical trials"

We conducted systematic review and meta-analysis to provide a comprehensive overview of outcomes in patients who underwent personalized genomics-based versus non-personalized treatment in oncology. The PubMed searches detected 803 studies based on phase II clinical trials’ results published from 2010 to 2021. We selected 50 studies, having 81 arms and 6536 patients for the analysis. We compared Response Rate (RR), medians and 1-year rates of Overall Survival (OS) and Progression-Free Survival (PFS) between genomics-based personalized and non-personalized arms. This repository contains final dataset (Dataset file) and the information on 803 studies identified in the literature search (803 studies description file). The searches, study selection, data extraction and synthesis were performed in accordance to PRISMA (preferred reporting items for systematic review and meta-analysis) guidelines. The research protocol was registered in PROSPERO (International prospective register of systematic reviews, https://www.crd.york.ac.uk/PROSPERO), record ID CRD42024504021. We performed proportional meta-analysis using the RStudio program, utilizing the R programming language and packages "meta", "metafor," and "tidyverse", the code is available at github: https://github.com/MikhailPot/PreciseOnco_meta-analysis

Authors

  • Potievskiy, Mikhail B. ;
  • Zharova, Elena P. ;
  • Nekrasova, Lidia A. ;
  • Garifullin, Airat I. ;
  • Korobov, Ivan V. ;
  • Shevchenko, Nikita E. ;
  • Zabolotneva, Anastasia A. ;
  • Atochin, Dmitriy N. ;
  • Kaprin, Andrei D. ;
  • Shegai, Peter V.
0 Citations0 Mentions79% FAIR0.3 Dataset Index
10.5281/zenodo.109662142025

Data for article "Personal approach for cancer treatment: a meta-analysis of Phase II Clinical trials"

We conducted systematic review and meta-analysis to provide a comprehensive overview of outcomes in patients who underwent personalized genomics-based versus non-personalized treatment in oncology. The PubMed searches detected 803 studies based on phase II clinical trials’ results published from 2010 to 2021. We selected 50 studies, having 81 arms and 6536 patients for the analysis. We compared Response Rate (RR), medians and 1-year rates of Overall Survival (OS) and Progression-Free Survival (PFS) between genomics-based personalized and non-personalized arms. This repository contains final dataset (Dataset file) and the information on 803 studies identified in the literature search (803 studies description file). The searches, study selection, data extraction and synthesis were performed in accordance to PRISMA (preferred reporting items for systematic review and meta-analysis) guidelines. The research protocol was registered in PROSPERO (International prospective register of systematic reviews, https://www.crd.york.ac.uk/PROSPERO), record ID CRD42024504021. We performed proportional meta-analysis using the RStudio program, utilizing the R programming language and packages "meta", "metafor," and "tidyverse", the code is available at github: https://github.com/MikhailPot/PreciseOnco_meta-analysis

Authors

  • Potievskiy, Mikhail B. ;
  • Zharova, Elena P. ;
  • Nekrasova, Lidia A. ;
  • Garifullin, Airat I. ;
  • Korobov, Ivan V. ;
  • Shevchenko, Nikita E. ;
  • Zabolotneva, Anastasia A. ;
  • Atochin, Dmitriy N. ;
  • Kaprin, Andrei D. ;
  • Shegai, Peter V.
0 Citations0 Mentions79% FAIR0.3 Dataset Index
10.5281/zenodo.151545472025

Data for article "Personal approach for cancer treatment: a meta-analysis of Phase II Clinical trials"

We conducted systematic review and meta-analysis to provide a comprehensive overview of outcomes in patients who underwent personalized genomics-based versus non-personalized treatment in oncology. The PubMed searches detected 803 studies based on phase II clinical trials’ results published from 2010 to 2021. We selected 50 studies, having 81 arms and 6536 patients for the analysis. We compared Response Rate (RR), medians and 1-year rates of Overall Survival (OS) and Progression-Free Survival (PFS) between genomics-based personalized and non-personalized arms. This repository contains final dataset. The searches, study selection, data extraction and synthesis were performed in accordance to PRISMA (preferred reporting items for systematic review and meta-analysis) guidelines. The research protocol was registered in PROSPERO (International prospective register of systematic reviews, https://www.crd.york.ac.uk/PROSPERO), record ID CRD42024504021. We performed proportional meta-analysis using the RStudio program, utilizing the R programming language and packages "meta", "metafor," and "tidyverse", the code is available at github: https://github.com/MikhailPot/PreciseOnco_meta-analysis

Authors

  • Potievskiy, Mikhail B. ;
  • Zharova, Elena P. ;
  • Nekrasova, Lidia A. ;
  • Garifullin, Airat I. ;
  • Korobov, Ivan V. ;
  • Shevchenko, Nikita E. ;
  • Zabolotneva, Anastasia A. ;
  • Atochin, Dmitriy N. ;
  • Kaprin, Andrei D. ;
  • Shegai, Peter V.
0 Citations0 Mentions79% FAIR0.3 Dataset Index
10.5281/zenodo.149962962025

Data for article "Personal approach for cancer treatment: a meta-analysis of Phase II Clinical trials"

We conducted systematic review and meta-analysis to provide a comprehensive overview of outcomes in patients who underwent personalized genomics-based versus non-personalized treatment in oncology. The PubMed searches detected 873 studies based on phase II clinical trials’ results published from 2010 to 2021. We selected 46 studies, having 81 arms and 6536 patients for the analysis. We compared Response Rate (RR), medians and 1-year rates of Overall Survival (OS) and Progression-Free Survival (PFS) between genomics-based personalized and non-personalized arms. This repository contains final dataset. The searches, study selection, data extraction and synthesis were performed in accordance to PRISMA (preferred reporting items for systematic review and meta-analysis) guidelines. The research protocol was registered in PROSPERO (International prospective register of systematic reviews, https://www.crd.york.ac.uk/PROSPERO), record ID CRD42024504021. We performed proportional meta-analysis using the RStudio program, utilizing the R programming language and packages "meta", "metafor," and "tidyverse", the code is available at github: https://github.com/MikhailPot/PreciseOnco_meta-analysis

Authors

  • Potievskiy, Mikhail B. ;
  • Zharova, Elena P. ;
  • Nekrasova, Lidia A. ;
  • Garifullin, Airat I. ;
  • Korobov, Ivan V. ;
  • Shevchenko, Nikita E. ;
  • Zabolotneva, Anastasia A. ;
  • Atochin, Dmitriy N. ;
  • Kaprin, Andrei D. ;
  • Shegai, Peter V.
0 Citations0 Mentions79% FAIR0.1 Dataset Index
10.5281/zenodo.109662152024